Efficient revascularization by VEGF administration via heparin-functionalized nanoparticle-fibrin complex.

We investigated the angiogenic bioactivity and therapeutic angiogenic effect of vascular endothelial growth factor (VEGF) administration by the heparin-functionalized nanoparticle-fibrin gel complex. The markedly increased bioactivity was observed by the VEGF-loaded nanoparticle-fibrin gel complex, compared to the VEGF-loaded fibrin gel, the nanoparticle-fibrin gel complex without VEGF, or fibrin gel (control) in terms of the capillary density in a mouse subcutaneous implantation model. Furthermore, the VEGF-loaded nanoparticle-fibrin gel complex significantly enhanced the therapeutic angiogenic effect in a rabbit ischemic hind limb model: the noticeable increase in the recovered calf blood pressure, the angiographic score, and the density of collaterals, as well as the stable maintenance of the organized collaterals, compared to the VEGF-loaded fibrin gel. These results show the enhanced angiogenic potential of VEGF administration by the proposed heparin-functionalized nanoparticle-fibrin gel complex.

[1]  A. Hoffman,et al.  PEG-cross-linked heparin is an affinity hydrogel for sustained release of vascular endothelial growth factor , 2006, Journal of biomaterials science. Polymer edition.

[2]  W. Saltzman,et al.  Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinking. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Wayne R. Gombotz,et al.  Calcium-alginate beads for the oral delivery of transforming growth factor-β1 (TGF-β1): stabilization of TGF-β1 by the addition of polyacrylic acid within acid-treated beads , 1994 .

[4]  T. Arakawa,et al.  Stoichiometry of heparin binding to basic fibroblast growth factor. , 1994, Archives of biochemistry and biophysics.

[5]  K. Plate,et al.  Vascular endothelial growth factor , 1997, Journal of Neuro-Oncology.

[6]  Roche ResearchCenter,et al.  Vascular Permeability Factor: A Tumor-derived Polypeptide that Induces Endothelial Cell and Monocyte Procoagulant Activity, and Promotes Monocyte Migration , 1990 .

[7]  J. Isner,et al.  Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. , 1998, The American journal of pathology.

[8]  S. Epstein,et al.  Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. , 1996, Circulation.

[9]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[10]  S. Epstein,et al.  Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. , 1994, Circulation.

[11]  Martin Ehrbar,et al.  Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[12]  A. G. Ding,et al.  Rescue of SCID murine ischemic hindlimbs with pH-modified rhbFGF/poly(DL-lactic-co-glycolic acid) implants. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Chad Johnson,et al.  The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. , 2004, Biomaterials.

[14]  M. J. Santander-Ortega,et al.  Colloidal stability of pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms. , 2006, Journal of colloid and interface science.

[15]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[16]  Jun Ho Kim,et al.  Asymmetrically porous PLGA/Pluronic F127 membrane for effective guided bone regeneration , 2006, Journal of biomaterials science. Polymer edition.

[17]  Didier Letourneur,et al.  Low Molecular Weight Fucoidan Increases VEGF165-induced Endothelial Cell Migration by Enhancing VEGF165 Binding to VEGFR-2 and NRP1* , 2006, Journal of Biological Chemistry.

[18]  A. Kawada,et al.  Alginate oligosaccharides stimulate VEGF-mediated growth and migration of human endothelial cells , 1999, Archives of Dermatological Research.

[19]  K. Takaoka,et al.  Heparin Potentiates the in Vivo Ectopic Bone Formation Induced by Bone Morphogenetic Protein-2* , 2006, Journal of Biological Chemistry.

[20]  D. Rifkin,et al.  Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation , 1988, The Journal of cell biology.

[21]  P. Vaupel,et al.  Therapeutic angiogenesis. , 1993, Archives of surgery.

[22]  B. Lévy,et al.  Vascular Endothelial Growth Factor‐B Promotes In Vivo Angiogenesis , 2003, Circulation research.

[23]  G. Tae,et al.  A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors. , 2006, Biomaterials.

[24]  Young Ha Kim,et al.  Accelerated Micellization and Aggregation of Pluronic Micelles by Interaction with Heparin , 2010, Journal of biomaterials science. Polymer edition.

[25]  J. Pearlman,et al.  Vascular endothelial growth factor administration in chronic myocardial ischemia. , 1996, The American journal of physiology.

[26]  Glenn D Prestwich,et al.  Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. , 2005, Biomaterials.

[27]  D. Connolly,et al.  Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration , 1990, The Journal of experimental medicine.

[28]  J. Feijen,et al.  Release of model proteins and basic fibroblast growth factor from in situ forming degradable dextran hydrogels. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[29]  K. Thomas Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic Agent (*) , 1996, The Journal of Biological Chemistry.

[30]  E. Brogi,et al.  Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. , 1994, The Journal of clinical investigation.

[31]  S. Oh,et al.  Fabrication and characterization of hydrophilized porous PLGA nerve guide conduits by a modified immersion precipitation method. , 2007, Journal of biomedical materials research. Part A.

[32]  Giyoong Tae,et al.  The effect of heparin on the gellation of Pluronic F-127 hydrogel , 2006 .

[33]  E. Bauer,et al.  Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells , 1992, Journal of cellular physiology.